Willingdon Wealth Management cut its stake in shares of CVS Health Corp (NYSE:CVS) by 5.4% in the second quarter, Holdings Channel.com reports. The institutional investor owned 26,611 shares of the pharmacy operator’s stock after selling 1,511 shares during the quarter. Willingdon Wealth Management’s holdings in CVS Health were worth $1,450,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in CVS. Westpac Banking Corp increased its stake in shares of CVS Health by 9.2% in the 2nd quarter. Westpac Banking Corp now owns 400,305 shares of the pharmacy operator’s stock worth $21,813,000 after purchasing an additional 33,706 shares in the last quarter. GFS Advisors LLC increased its stake in shares of CVS Health by 26.6% in the 2nd quarter. GFS Advisors LLC now owns 55,605 shares of the pharmacy operator’s stock worth $3,030,000 after purchasing an additional 11,675 shares in the last quarter. Wedbush Securities Inc. increased its stake in shares of CVS Health by 40.9% in the 2nd quarter. Wedbush Securities Inc. now owns 41,618 shares of the pharmacy operator’s stock worth $2,268,000 after purchasing an additional 12,078 shares in the last quarter. Sheaff Brock Investment Advisors LLC increased its stake in shares of CVS Health by 11.2% in the 2nd quarter. Sheaff Brock Investment Advisors LLC now owns 16,489 shares of the pharmacy operator’s stock worth $898,000 after purchasing an additional 1,655 shares in the last quarter. Finally, Robecosam AG increased its stake in shares of CVS Health by 17.8% in the 2nd quarter. Robecosam AG now owns 220,965 shares of the pharmacy operator’s stock worth $12,096,000 after purchasing an additional 33,409 shares in the last quarter. Institutional investors and hedge funds own 77.18% of the company’s stock.
Several research firms have recently commented on CVS. Citigroup upped their price objective on CVS Health from $68.00 to $72.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. UBS Group dropped their target price on shares of CVS Health from $74.00 to $67.00 and set a “sell” rating for the company in a report on Thursday, May 2nd. Evercore ISI set a $63.00 target price on shares of CVS Health and gave the stock a “buy” rating in a report on Wednesday, August 7th. BMO Capital Markets set a $63.00 target price on shares of CVS Health and gave the stock a “hold” rating in a report on Friday, May 3rd. Finally, CIBC reaffirmed a “market perform” rating on shares of CVS Health in a report on Monday, April 15th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $75.14.
CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the consensus estimate of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The business had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same quarter in the prior year, the firm earned $1.69 EPS. The business’s revenue was up 35.2% on a year-over-year basis. On average, equities analysts anticipate that CVS Health Corp will post 6.96 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 2nd. Shareholders of record on Thursday, July 25th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.34%. The ex-dividend date was Wednesday, July 24th. CVS Health’s dividend payout ratio (DPR) is presently 28.25%.
About CVS Health
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Featured Article: What are the benefits of a portfolio tracker?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.